Skip to content

Arthroscopic Treatment Combine With TXA for Elbow Stiffness

Prospective Randomized Controlled Study on Arthroscopic Treatment Combine With TXA for Elbow Stiffness

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05138913
Enrollment
80
Registered
2021-12-01
Start date
2020-12-01
Completion date
2023-12-30
Last updated
2021-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elbow Stiffness, Tranexamic Acid

Brief summary

This study is a prospective randomized controlled study of different arthroscopic treatments for elbow stiffness combined with tranexamic acid(TXA) injection. The patients with stiffness were randomly divided into groups before the operation. After the arthroscopic operation was completed, they were divided into a local TXA injection group and a control group (normal saline) to perform additional operations for reduction of hemorrhage. In different time periods, the quantitative and qualitative indicators including pain, functional score, range of motion, level of Hemoglobin, the circumference of the limb 10cm above and below the elbow, amount of hemorrhage, etc. were compared between groups at the same time period to evaluate the difference in the effect of arthroscopic treatment combined with TXA on the treatment of reduction of hemorrhage. Determine the effectiveness of TXA.

Interventions

DRUGTXA

After the arthroscopic operation was completed, a local TXA injection was performed

DRUGSaline

After the arthroscopic operation was completed, a local saline injection was performed

Sponsors

Beijing Jishuitan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Clinically diagnosed patients with elbow stiffness Young and middle-aged patients aged 18 to 60 with failed nonoperated treatment Voluntarily accept randomized controlled grouping, cooperate with treatment and follow up patients No other comorbidities or medical diseases affect the surgical patients -

Exclusion criteria

Elderly people older than 60 years old and patients younger than 18 years old With severe comorbidities or medical diseases affect the surgical patients \-

Design outcomes

Primary

MeasureTime frameDescription
Mayo Elbow Performance Scorebaseline-6 months postoperativelyA score used to evaluated the elbow function

Secondary

MeasureTime frameDescription
Visual analogue scalebaseline-6 months postoperativelyA score used to evaluated the pain
Circumference of upper extremitybaseline-6 months postoperatively
change of hemoglobinbaseline-6 months postoperatively
range of motionbaseline-6 months postoperativelyflexion, extension, pronation and supination of elbow

Countries

China

Contacts

Primary ContactShangzhe Li, M.D.
562744381@qq.com+86 13826162999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026